metformin has been researched along with Infections, Listeria in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pearce, EL | 1 |
| Walsh, MC | 1 |
| Cejas, PJ | 1 |
| Harms, GM | 1 |
| Shen, H | 1 |
| Wang, LS | 1 |
| Jones, RG | 1 |
| Choi, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.[NCT04387630] | Phase 2/Phase 3 | 120 participants (Anticipated) | Interventional | 2020-06-05 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for metformin and Infections, Listeria
| Article | Year |
|---|---|
Enhancing CD8 T-cell memory by modulating fatty acid metabolism.
Topics: Adaptor Proteins, Signal Transducing; Animals; CD8-Positive T-Lymphocytes; Fatty Acids; Hypoglycemic | 2009 |